My Profile
C.R. Bard, Inc. Customer Service Contacts
C.R. Bard, Inc., a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies, specializes in vascular, urology, oncology, and surgical specialty products. Founded in 1907 and headquartered in Murray Hill, New Jersey, Bard is renowned for its commitment to advancing the delivery of high-quality healthcare and continuously improving patient outcomes. By focusing on product development and acquiring technologies that complement its existing portfolio, Bard remains at the forefront of the medical devices industry, ensuring broad global access to its state-of-the-art products.
Phone Number & Contact Info
-
- C.R. Bard, Inc. Most Popular Number
- 800-367-2273
-
- Website
- en.wikipedia.org
-
- Opening Hours:
- 24 hours, 7 days
-
- Additional Contact numbers:
- 908-277-8000
-
- Mailing Address:
- Murray Hill, New Providence, NJ
C.R. Bard, Inc. Customer Service Overview
C.R. Bard, Inc. has an overall customer service rating of 5 out of 5. Their rate for resolving issues is 100%, and customer sentiment is very satisfied. When calling, customers experience an average hold time of less than a minute.
Top Reasons Customers Contact C.R. Bard, Inc.
Customers contact C.R. Bard, Inc. for various reasons. Most popular of them are questions like "Are there any job openings at C.R. Bard, Inc.?", "What products does C.R. Bard, Inc. manufacture?", "Where are C.R. Bard, Inc.'s headquarters located?".
User Testimonials for C.R. Bard, Inc. Support
-
Kind and understanding service by Mellisa M, who deserves a raise.
From Brian H Esz at 2023-03-22
Frequently Asked Questions About C.R. Bard, Inc.
Explore frequently asked questions about C.R. Bard, Inc. to quickly find the information and support you need.
29, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health care industry leader with approximately $16 billion in annualized revenue.
C.R. Bard is a medical technology company specializing in vascular, urology, surgery and oncology devices.
Gemini, formerly known as Bard, is a generative artificial intelligence chatbot developed by Google.
In April 2017, C. R. Bard announced that it would be acquired by Becton, Dickinson and Company (BD). The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard.